1 / 6

Baseline Characteristics by Baseline N-BNP Level

This study by the Heart Protection Study Collaborative Group investigates the relationship between baseline N-BNP levels and the risk of major vascular events, stroke, coronary events, and heart failure hospitalization or death. It analyzes the relative hazard of these outcomes adjusted for baseline characteristics, and evaluates the effects of simvastatin on vascular events and mortality across different N-BNP levels. The findings underscore the implications of N-BNP as a prognostic marker in cardiovascular health and the treatment efficacy of simvastatin.

knox
Télécharger la présentation

Baseline Characteristics by Baseline N-BNP Level

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Baseline Characteristics by Baseline N-BNP Level Heart Protection Study Collaborative Group. J Am Coll Cardiol 2007;49:311-9

  2. Risk of Major Vascular Events, Stroke, Major Coronary Events, and Heart Failure Hospitalization or Death, by Baseline N-BNP Level Heart Protection Study Collaborative Group. J Am Coll Cardiol 2007;49:311-9

  3. Relative Hazard of Vascular Events and Hospitalization or Death Due to HF by Baseline N-BNP Level (Adjusted for Differences in Baseline Characteristics) Heart Protection Study Collaborative Group. J Am Coll Cardiol 2007;49:311-9

  4. Effects of Simvastatin on Vascular Events in Participants Subdivided by Baseline N-BNP Level Heart Protection Study Collaborative Group. J Am Coll Cardiol 2007;49:311-9

  5. Absolute Benefits of Simvastatin Allocation on First MVE and First MCE, by Baseline N-BNP Level Heart Protection Study Collaborative Group. J Am Coll Cardiol 2007;49:311-9

  6. Effects of Simvastatin on Vascular and Nonvascular Mortality in Participants Subdivided by Baseline N-BNP Level Heart Protection Study Collaborative Group. J Am Coll Cardiol 2007;49:311-9

More Related